Cas:1241678-97-6 (1S)-1-[3-fluoro-4-(trifluoromethyl)phenyl]propan-1-amine manufacturer & supplier

Chemical Name:(1S)-1-[3-fluoro-4-(trifluoromethyl)phenyl]propan-1-amine

CAS.NO:1241678-97-6

Synonyms:(S)-1-(3-fluoro-4-(trifluoromethyl)phenyl)propan-1-amine

Molecular Formula:C₁₀H₁₁F₄N

Molecular Weight:221.19500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:26.02000

Exact Mass:221.08300

LogP:3.95460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (S)-1-(3-fluoro-4-(trifluoromethyl)phenyl)propan-1-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-1-(3-fluoro-4-(trifluoromethyl)phenyl)propan-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-1-(3-fluoro-4-(trifluoromethyl)phenyl)propan-1-amine Use and application,(S)-1-(3-fluoro-4-(trifluoromethyl)phenyl)propan-1-amine technical grade,usp/ep/jp grade.

Related News: The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. 3-(4,5-di(benzyloxy)-2-aminophenyl)-4-(hydroxymethyl)-6,7-di(benzyloxy)quinoline manufacturers The company’s contract arm churns out more than 250 metric tons of commercial APIs every year for injectables, inhalables, highly potent, cytotoxic and controlled substances, according to a release. 2-Brom-6-(2-aminoethoxy)-pyridin suppliers While Stevanato has been in the headlines for its involvement in the fight against Covid-19—its factories immediately sprang to work producing vials and syringes for vaccines when Italy was still under lockdown in April 2020—vaccines only made up 4% of the company’s revenues in 2020 and 2019. 4-((2s,5s)-5-butyl-1,3-dithian-2-yl)benzonitrile vendor & factory While Stevanato has been in the headlines for its involvement in the fight against Covid-19—its factories immediately sprang to work producing vials and syringes for vaccines when Italy was still under lockdown in April 2020—vaccines only made up 4% of the company’s revenues in 2020 and 2019. ,The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients.